| Both the Indiana and Florida rulings were preliminary—the cases are still playing out in their respective courts, with final decisions from the district judges still uncertain.
But the Arkansas ruling, issued yesterday, represents a final decision and is the first final merits ruling on a state law banning gender transition treatments for minors.
The decision comes in a lawsuit (Brandt et al v. Rutledge et al) filed by several Arkansas families with transgender children, who were represented by the American Civil Liberties Union.
“Transgender kids across the country are having their own futures threatened by laws like this one, and it’s up to all of us to speak out, fight back, and give them hope,” said Dylan Brandt, a 17-year-old transgender boy and one of the suit’s plaintiffs, in a statement.
“The undisputed evidence at trial established that, if the Act were to go into effect, (i) three of the Minor Plaintiffs—Parker Saxton, Dylan Brandt, and Sabrina Jennen—would have to discontinue treatment that they, their parents, and their doctors all agree is medically indicated for them and benefitting their health and well-being, and Minor Plaintiff Brooke Dennis would be unable to obtain treatment she will imminently need,” wrote James M. Moody Jr. of the U.S. District Court for the Eastern District of Arkansas in yesterday’s decision. In addition, “the Physician Plaintiff, Dr. Kathryn Stambough, would be unable to treat her patients who need care, leaving them to suffer, and unable to refer them to other doctors to provide care when necessary.” Thus, the plaintiffs had standing to bring the case.
As to the Equal Protection Clause claim, the judge noted that “Act 626 discriminates
on the basis of sex because a minor’s sex at birth determines whether the minor can
receive certain types of medical care under the law.” For instance, a minor being treated for conditions other than gender dysphoria could still be prescribed hormones. The law is therefore a sex-based classification that “discriminates against transgender people,” the judge wrote.
“The evidence at trial showed that the prohibited medical care improves the health
and well-being of many adolescents with gender dysphoria,” continued the decision, which spent pages detailing expert testimony on both the benefits and risks of various treatments for childhood gender dysphoria.
For instance, “it is undisputed that when estrogen is used to treat birth-assigned males, it can sometimes impair their fertility” and “estrogen treatment follows puberty blockers at certain stages of the adolescent’s development, the adolescent can become infertile.” And “when estrogen or anti-androgens are given to birth-assigned males, the hormones can limit the patient’s sexual arousal or ability to orgasm,” the judge points out. But “these risks are discussed with patients and parents. The risks can be managed by the doctor to preserve fertility or treatment can be provided to address a decrease in sexual satisfaction in most cases.”
In other words, the ruling doesn’t shy away from acknowledging the drawbacks involved in certain gender transition treatments. But it situates these firmly in the realm of considerations to be left to patients and doctors, not the state.
“Even if the Court found that Act 626 passed constitutional muster under the Equal
Protection Clause, it fails under due process analysis,” states the decision. “As the Court has previously found, the Parent Plaintiffs have a fundamental right to seek medical care for their children and, in conjunction with their adolescent child’s consent and their doctor’s recommendation, make a judgment that medical care is necessary.”
You can read the whole decision here. Attorney Gabriel Malor has a thread summarizing some of the decision’s key points here: |